Form 8-K

8-K — Elmet Group Co.

Accession: 0001213900-26-101918

Filed: 2026-09-22

Period: 2026-09-21

CIK: 0002101698

SIC: 3490 (MISCELLANEOUS FABRICATED METAL PRODUCTS)

Item: Entry into a Material Definitive Agreement

Item: Unregistered Sales of Equity Securities

Item: Financial Statements and Exhibits

Documents

8-K — ea0306130-8k_elmet.htm (Primary)

EX-4.1 — COMMON STOCK PURCHASE WARRANT (ea030613001ex4-1.htm)

EX-10.1 — WARRANT PURCHASE AGREEMENT, DATED SEPTEMBER 21, 2026, BY AND BETWEEN THE ELMET GROUP CO. AND BLUE MOON METALS INC (ea030613001ex10-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: ea0306130-8k_elmet.htm · Sequence: 1

false

0002101698

2026-09-21

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):

September 21, 2026

The Elmet Group Co.

(Exact name of registrant as specified in its charter)

Delaware

001-43245

33-1881598

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

280 Fore Street, Suite 301

Portland, Maine 04101

(Address of principal executive offices, including

zip code)

Registrant’s telephone number, including

area code: (207) 518-6791

Check the appropriate box

below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following

provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b)

of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.001 per share

ELMT

The Nasdaq Stock Market LLC

Indicate by check mark whether

the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule

12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company,

indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial

accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01. Entry into a Material Definitive Agreement.

Pursuant to the previously disclosed binding letter

agreement (the “Letter Agreement”), dated September 11, 2026, by and between The Elmet Group Co., a Delaware corporation (the

“Company,” “we,” “us” or “our”) and Blue Moon Metals Inc. (“Blue Moon”), on

September 21, 2026, the Company entered into a warrant purchase agreement (the “Purchase Agreement”) with Blue Moon pursuant

to which the Company agreed to issue and sell to Blue Moon an unregistered warrant (the “Warrant”) to purchase up to 1,166,970

shares (the “Warrant Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”)

in consideration of Blue Moon’s entry into the Letter Agreement and its agreement to perform its obligations thereunder, including

Blue Moon’s investment in the Company as contemplated by the Letter Agreement.

The Purchase Agreement includes customary representations,

warranties and covenants by the Company and Blue Moon. The representations, warranties and covenants contained in the Purchase Agreement

were made only for the purposes of such agreement and as of the specific dates, were solely for the benefit of the parties to such agreement

and may be subject to limitations agreed upon by the contracting parties. Additionally, the Company and Blue Moon have agreed to provide

the other party with customary indemnification under the Purchase Agreement

The Warrant has an exercise price of $21.423 per

share of Common Stock (as adjusted from time to time in accordance with the terms therein) and will be exercisable at any time and from

time to time, in whole or in part, subject to certain beneficial ownership limitations, beginning six (6) months from the date of issuance

and will expire three (3) years from the date of issuance.

The Warrant may also be exercised on a cashless

basis if there is no effective registration statement registering, or the prospectus contained therein is not available for, the resale

of the Warrant Shares by the holder. The holder of the Warrant may not exercise the Warrant to the extent that such exercise would result

in the number of shares of Common Stock beneficially owned by such holder and its affiliates exceeding 4.99% of the total number of shares

of Common Stock outstanding immediately after giving effect to the exercise, which percentage may be increased or decreased at the holder’s

election not to exceed 19.99%. In the event of certain fundamental transactions (as defined in the Warrant), the holder of the Warrant

will have the right to receive, upon exercise of the Warrant, the same amount and kind of securities, cash or property as it would have

been entitled to receive upon the occurrence of such fundamental transaction if it had been, immediately prior to such fundamental transaction,

the holder of the number of Warrant Shares then issuable upon exercise in full of the Warrant.

The foregoing summaries of the Warrant and the

Purchase Agreement do not purport to be complete and are subject to and are qualified in their entirety by reference to the full text

of such agreements, copies of which are filed as Exhibits 4.1 and 10.1, respectively, to this Current Report on Form 8-K and are incorporated

herein by reference.

Item 3.02. Unregistered Sale of Equity

Securities.

The offer and sale of the Warrant pursuant to

the Purchase Agreement, was made in reliance upon an exemption from registration under the Securities Act of 1933, as amended (the “Securities

Act”), pursuant to Section 4(a)(2) thereof. Any shares of Common Stock deliverable upon exercise of the Warrant will be issued in

reliance upon the exemption from registration in Section 3(a)(9) or Section 4(a)(2) of the Securities Act, respectively. A detailed description

of the Warrant is included in, and is incorporated into this Item 3.02 by reference to, Item 1.01 above.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

The following exhibits are

being filed herewith:

Exhibit No.

Description

4.1

Common Stock Purchase Warrant

10.1+

Warrant Purchase Agreement, dated September 21, 2026, by and between The Elmet Group Co. and Blue Moon Metals Inc.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

+ Certain portions of this exhibit (indicated by “[*]”)

have been omitted pursuant to Item 601(a)(6) of Regulation S-K.

SIGNATURE

Pursuant to the requirements

of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto

duly authorized.

Dated: September 22, 2026

The Elmet Group Co.

By:

/s/ Peter V. Anania

Name:

Peter V. Anania

Title:

Chief Executive Officer and Chairman

EX-4.1 — COMMON STOCK PURCHASE WARRANT

EX-4.1

Filename: ea030613001ex4-1.htm · Sequence: 2

Exhibit

4.1

THIS

WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON THE EXERCISE OF THIS WARRANT (THE “SECURITIES”) HAVE NOT BEEN REGISTERED

UNDER SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES.

THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED UNLESS (I) SUCH SECURITIES HAVE BEEN REGISTERED

FOR SALE PURSUANT TO THE SECURITIES ACT, (II) SUCH SECURITIES MAY BE SOLD PURSUANT TO RULE 144, (III) THE COMPANY HAS RECEIVED AN OPINION

OF COUNSEL REASONABLY SATISFACTORY TO IT THAT SUCH TRANSFER MAY LAWFULLY BE MADE WITHOUT REGISTRATION UNDER THE SECURITIES ACT, OR (IV)

THE SECURITIES ARE TRANSFERRED WITHOUT CONSIDERATION TO AN AFFILIATE OF SUCH HOLDER OR A CUSTODIAL NOMINEE (WHICH FOR THE AVOIDANCE OF

DOUBT SHALL REQUIRE NEITHER CONSENT NOR THE DELIVERY OF AN OPINION).

WARRANT

TO PURCHASE COMMON STOCK

Number

of Shares: 1,166,970

(subject

to adjustment)

Original

Issue Date: September 21, 2026

THE

ELMET GROUP CO., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration,

the receipt and sufficiency of which are hereby acknowledged, Blue Moon Metals Inc. or its registered assigns (the “Holder”),

is entitled, subject to the terms set forth below, to purchase from the Company up to a total of 1,166,970 shares of common stock, par

value $0.001 per share (the “Common Stock”), of the Company (each such share, a “Warrant Share”

and all such shares, the “Warrant Shares”) at an exercise price per share equal to $21.423 (the “Exercise

Price”), in each case as adjusted from time to time as provided in Section 9, upon surrender of this Warrant to Purchase

Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”)

at any time and from time to time on or after the date that is six (6) months following the Original Issue Date (the “Initial

Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on September 21, 2029 (the “Termination Date”)

but not thereafter.

This

Warrant is issued pursuant to that certain Securities Purchase Agreement, dated September 21, 2026, by and among the Company and the

Holder (the “Purchase Agreement”).

Definitions. For purposes of this Warrant, the following terms shall have the following meanings:

“Affiliate”

means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediates, controls, is controlled

by or is under common control with such Person.

“Attribution

Parties” means, collectively, the following Persons and entities: (i) any direct or indirect Affiliates of the Holder, (ii)

any investment vehicle, including, any funds, feeder funds or managed accounts, currently, or from time to time after the date hereof,

directly or indirectly managed or advised by the Holder’s investment manager or any of its Affiliates or principals, (iii) any

Person acting or who could be deemed to be acting as a Group together with the Holder or any Attribution Parties and (iv) any other Persons

whose beneficial ownership of the Company’s Common Stock would or could be aggregated with the Holder’s and/or any other

Attribution Parties for purposes of Section 13(d) or Section 16 of the Exchange Act. For clarity, the purpose of the foregoing is to

subject collectively the Holder and all other Attribution Parties to the Maximum Percentage.

“Closing

Sale Price” means, for any security as of any date, the last trade price for such security on the Principal Trading Market

for such security, as reported by Bloomberg Financial Markets, or, if such Principal Trading Market begins to operate on an extended

hours basis and does not designate the last trade price, then the last trade price of such security prior to 4:00 P.M., New York City

time, as reported by Bloomberg Financial Markets, or if the foregoing do not apply, the last trade price of such security in the over-the-counter

market on the electronic bulletin board for such security as reported by Bloomberg Financial Markets. If the Closing Sale Price cannot

be calculated for a security on a particular date on any of the foregoing bases, the Closing Sale Price of such security on such date

shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree

upon the fair market value of such security, then the Board of Directors of the Company shall use its good faith judgment to determine

the fair market value. The Board of Directors’ determination shall be binding upon all parties absent demonstrable error. All such

determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during

the applicable calculation period.

“Commission”

means the U.S. Securities and Exchange Commission.

“Exchange

Act” means the U.S. Securities Exchange Act of 1934, as amended, and all of the rules and regulations promulgated thereunder.

“Group”

shall have the meaning ascribed to it in Section 13(d) of the Exchange Act, and all related rules, regulations and jurisprudence.

“Person”

means an individual, partnership, corporation, limited liability company, business trust, joint stock company, trust, incorporated or

unincorporated association, joint venture, government (or an agency or subdivision thereof) or any other entity or organization.

“Principal

Trading Market” means the national securities exchange or other trading market on which the Common Stock is primarily listed

on and quoted for trading, which, as of the Original Issue Date, shall be the Nasdaq Capital Market.

“Securities

Act” means the U.S. Securities Act of 1933, as amended, and all of the rules and regulations promulgated thereunder.

“Standard

Settlement Period” means the standard settlement period, expressed in a number of Trading Days, for the Principal Trading Market

with respect to the Common Stock that is in effect on the date of delivery of an applicable Exercise Notice, which as of the Original

Issue Date was “T+1.”

“Trading

Day” means any weekday on which the Principal Trading Market is normally open for trading.

“Trading

Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date

in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York

Stock Exchange (or any successors to any of the foregoing).

“Transfer

Agent” means Continental Stock Transfer & Trust Company, the Company’s transfer agent and registrar for the Common

Stock, and any successor appointed in such capacity.

“VWAP”

means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed

on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the

Trading Market on which the Common Stock is then listed as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City

time) to 4:02 p.m. (New York City time)), (b) if the Common Stock is not then listed on a Trading Market but is quoted on the OTCQB or

OTCQX (or successor to either of them), the volume weighted average price per share of the Common Shares for such date (or the nearest

preceding date) on such market on such date of the Common Stock for such date (or the nearest preceding date) on the OTCQB or OTCQX (or

successor to either of them), as applicable, (c) if the Common Stock is not then listed or quoted for trading on a Trading Market or

on the OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency

succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all

other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the

holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of

which shall be paid by the Company.

Issuance of Securities; Registration of Warrants. The Company shall register ownership of this Warrant, upon records to be

maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder (which shall

include the initial Holder or, as the case may be, any assignee to which this Warrant is permissibly assigned hereunder) from time to

time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise

hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

3. Registration

of Transfers.

(a) Subject

to compliance with any applicable securities laws, the conditions set forth in Section 3(b) hereof and the provisions of Section 6.1

of the Purchase Agreement, this Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant

at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the

form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon

the making of such transfer. Subject to compliance with all applicable securities laws, the Company shall register the transfer of all

or any portion of this Warrant in the Warrant Register, upon surrender of this Warrant, and payment for all applicable transfer taxes

(if any). Upon any such registration or transfer, a new warrant to purchase Common Stock in substantially the form of this Warrant (any

such new warrant, a “New Warrant”) evidencing the portion of this Warrant so transferred shall be issued to the transferee,

and a New Warrant evidencing the remaining portion of this Warrant not so transferred, if any, shall be issued to the transferring Holder.

The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance by such transferee of all of the rights and

obligations in respect of the New Warrant that the Holder has in respect of this Warrant. The Company shall prepare, issue and deliver

at the Company’s own expense any New Warrant under this Section 3. Until due presentment for registration of transfer, the

Company may treat the registered Holder hereof as the owner and holder for all purposes, and the Company shall not be affected by any

notice to the contrary.

(b) Transfer

Restrictions. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this

Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable

state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information

requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of

this Warrant, as the case may be, comply with the provisions of Section 6.1 of the Purchase Agreement. Notwithstanding anything to the

contrary in this Warrant, the Holder may not sell, assign, transfer, pledge, hypothecate, or otherwise dispose of this Warrant (or any

portion thereof or any rights hereunder), whether voluntarily or by operation of law, to any Restricted Entity. “Restricted Entity”

shall have the meaning as set forth in the Company’s Restricted Entity Compliance Plan dated as of September 14, 2026 (as may be

amended, modified or supplemented from time to time). The foregoing restriction is in addition to, and not in lieu of, any other transfer

restrictions contained in this Warrant or in any other agreement between the Company and the Holder.

4. Exercise

of Warrants.

(a) All

or any part of this Warrant shall be exercisable by the registered Holder in any manner permitted by this Warrant (including Section

11) at any time and from time to time on or after the Initial Exercise Date and on or before the Termination Date.

(b) The

Holder may exercise this Warrant by delivering to the Company (i) an exercise notice, in the form attached as Schedule 1 hereto

(the “Exercise Notice”), completed and duly signed, and (ii) payment of the Exercise Price for the number of Warrant

Shares as to which this Warrant is being exercised (which may take the form of a “cashless exercise” if so indicated in the

Exercise Notice pursuant to Section 10 below), and the date on which the last of such items is delivered to the Company (as determined

in accordance with the notice provisions hereof) is an “Exercise Date.” The Holder shall not be required to deliver

the original Warrant in order to effect an exercise hereunder. No ink original Exercise Notice shall be required, nor shall any medallion

guarantee (or other type of guarantee or notarization) of any Exercise Notice be required. Execution and delivery of the Exercise Notice

shall have the same effect as cancellation of the original Warrant and issuance of a New Warrant evidencing the right to purchase the

remaining number of Warrant Shares, if any. The delivery by (or on behalf of) the Holder of the Exercise Notice and the applicable Exercise

Price as provided above shall constitute the Holder’s certification to the Company that, in the case of an exercise for cash, its

representations contained in Sections 5.1 through 5.6 of the Purchase Agreement are true and correct as of the Exercise Date as if remade

in their entirety (or, in the case of any transferee Holder that is not a party to the Purchase Agreement or, in the case of a cashless

exercise, its representations contained in Sections 5.1 and 5.2 of the Purchase Agreement, such transferee Holder’s certification

to the Company that such representations are true and correct as to such transferee Holder as of the Exercise Date). The Holder and the

Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver

any objection to any Notice of Exercise within two (2) Trading Days of receipt of such notice.

exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the

effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant

Shares purchased. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions

of this section, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase

hereunder at any given time may be less than the amount stated on the face hereof. If this Warrant shall have been exercised in part,

the Company shall, at the request of the Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant

Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for

by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.

(d) The

shares of Common Stock received upon exercise of this Warrant shall, unless an Unrestricted Condition (as defined below),- be stamped

or imprinted with a legend in substantially the following form:

“THE

SHARES OF COMMON STOCK REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES

ACT”), AND HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED UNLESS (I) SUCH SHARES HAVE BEEN REGISTERED

FOR SALE PURSUANT TO THE SECURITIES ACT, (II) SUCH SHARES MAY BE SOLD PURSUANT TO RULE 144, (III) THE COMPANY HAS RECEIVED AN OPINION

OF COUNSEL REASONABLY SATISFACTORY TO IT THAT SUCH TRANSFER MAY LAWFULLY BE MADE WITHOUT REGISTRATION UNDER THE SECURITIES ACT, OR (IV)

THE SHARES ARE TRANSFERRED WITHOUT CONSIDERATION TO AN AFFILIATE OF SUCH HOLDER OR A CUSTODIAL NOMINEE (WHICH FOR THE AVOIDANCE OF DOUBT

SHALL REQUIRE NEITHER CONSENT NOR THE DELIVERY OF AN OPINION).

5. Delivery

of Warrant Shares.

(a) Upon

exercise of this Warrant, the Company shall promptly (but in no event later than the number of Trading Days comprising the Standard Settlement

Period following the Exercise Date), upon the request of the Holder, cause the Transfer Agent to credit such aggregate number of shares

of Common Stock specified by the Holder in the Exercise Notice and to which the Holder is entitled pursuant to such exercise (the “Exercise

Shares”) to (i) the Holder’s or its designee’s balance account with The Depository Trust Company (“DTC”)

through its Deposit Withdrawal At Custodian system or (ii) in book-entry form via a direct registration system (“DRS”)

maintained by or on behalf of the Transfer Agent, in each case, so long as either (A) there is an effective Registration Statement on

Form S-3 permitting the resale of the Exercise Shares by the Holder or (B) the Exercise Shares are eligible for resale by the Holder

without volume or manner-of-sale restrictions pursuant to Rule 144 promulgated under the Securities Act (assuming cashless exercise of

this Warrant) (each of a (A) and (B), an “Unrestricted Condition”). If neither Unrestricted Condition is true, the

Company shall cause the Transfer Agent to either (i) record the Exercise Shares in the name of the Holder or its designee on the certificates

reflecting the Exercise Shares with an appropriate legend regarding restriction on transferability, which shall be issued and dispatched

by overnight courier to the address as specified in the Exercise Notice, and on the Company’s share register or (ii) issue such

Exercise Shares in the name of the Holder or its designee in restricted book-entry form in the Company’s share register. The Holder,

or any Person so designated by the Holder to receive Warrant Shares, shall be deemed to have become the holder of record of such Warrant

Shares as of the Exercise Date, irrespective of the date such Warrant Shares are credited to the Holder’s DTC account, the date

of the book entry positions or the date of delivery of the certificates evidencing such Exercise Shares, as the case may be.

(b) To

the extent permitted by law, the Company’s obligations to issue and deliver Warrant Shares in accordance with and subject to the

terms hereof (including the limitations set forth in Section 11 below) are absolute and unconditional, irrespective of any action

or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment

against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach

or alleged breach by the Holder or any other Person of any obligation to the Company or any violation or alleged violation of law by

the Holder or any other Person, and irrespective of any other circumstance that might otherwise limit such obligation of the Company

to the Holder in connection with the issuance of Warrant Shares. Nothing herein shall limit the Holder’s right to pursue any other

remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive

relief with respect to the Company’s failure to timely deliver Exercise Shares; provided, however, that the Holder shall not be

entitled to both (i) require the Company to reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such

exercise was not timely honored and (ii) receive the number of shares of Common Stock that would have been issued if the Company had

timely complied with its delivery requirements under Section 5(a).

6. Charges,

Taxes and Expenses. Issuance and delivery of Exercise Shares shall be made without charge to the Holder for any issue or transfer

tax, transfer agent fee or other incidental tax or expense (excluding any applicable stamp duties) in respect of the issuance of such

shares, all of which taxes and expenses shall be paid by the Company; provided, however, that the Company shall not be required to pay

any tax that may be payable in respect of any transfer involved in the registration of any Warrant Shares or the Warrants in a name other

than that of the Holder or an Affiliate thereof. The Holder shall be responsible for all other tax liability that may arise as a result

of holding or transferring this Warrant or receiving Warrant Shares upon exercise hereof.

7. Replacement

of Warrant. If this Warrant is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange

and substitution for and upon cancellation hereof, or in lieu of and substitution for this Warrant, a New Warrant, but only upon receipt

of evidence reasonably satisfactory to the Company of such loss, theft or destruction (in such case) and, in each case, a customary and

reasonable contractual indemnity, if requested by the Company. If a New Warrant is requested as a result of a mutilation of this Warrant,

then the Holder shall deliver such mutilated Warrant to the Company as a condition precedent to the Company’s obligation to issue

the New Warrant.

8. Reservation

of Warrant Shares. The Company covenants that it will, at all times while this Warrant is outstanding, reserve and keep available

out of the aggregate of its authorized but unissued and otherwise unreserved Common Stock, solely for the purpose of enabling it to issue

Warrant Shares upon exercise of this Warrant as herein provided, the number of Warrant Shares that are at times issuable and deliverable

upon the exercise of this entire Warrant (without regard to any limitations or restrictions on exercise of this Warrant, including without

limitation, the Maximum Percentage (as defined below)), free from preemptive rights or any other contingent purchase rights of persons

other than the Holder (taking into account the adjustments and restrictions of Section 9). The Company covenants that all Warrant

Shares so issuable and deliverable shall, upon issuance and the payment of the applicable Exercise Price in accordance with the terms

hereof, be duly and validly authorized, issued and fully paid and non-assessable. The Company will take all such action as may be reasonably

necessary to assure that such shares of Common Stock may be issued as provided herein without violation of any applicable law or regulation,

or of any requirements of any securities exchange or automated quotation system upon which the Common Stock may be listed.

9. Certain

Adjustments. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant (the “Number of

Warrant Shares”) are subject to adjustment from time to time as set forth in this Section 9.

(a) Stock

Dividends and Splits. If the Company, at any time while this Warrant is outstanding, (i) pays a stock dividend on its Common Stock

or otherwise makes a distribution on any class of capital stock issued and outstanding on the Original Issue Date and in accordance with

the terms of such stock on the Original Issue Date or as amended, that is payable in shares of Common Stock, (ii) subdivides its outstanding

shares of Common Stock into a larger number of shares of Common Stock, (iii) combines its outstanding shares of Common Stock into a smaller

number of shares of Common Stock or (iv) issues by reclassification of shares of capital stock any additional shares of Common Stock

of the Company, then in each such case the Number of Warrant Shares shall be multiplied by a fraction, the numerator of which shall be

the number of shares of Common Stock outstanding immediately after such event and the denominator of which shall be the number of shares

of Common Stock outstanding immediately before such event. Any adjustment made pursuant to clause (i) of this paragraph shall become

effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution,

provided, however, that if such record date shall have been fixed and such dividend is not fully paid on the date fixed therefor, the

Number of Warrant Shares shall be recomputed accordingly as of the close of business on such record date and thereafter the Number of

Warrant Shares shall be adjusted pursuant to this paragraph as of the time of actual payment of such dividends. Any adjustment pursuant

to clause (ii), (iii) or (iv) of this paragraph shall become effective immediately after the effective date of such subdivision, combination

or issuance.

(b) Pro

Rata Distributions. If, on or after the Original Issue Date, the Company shall declare or make any dividend or other pro rata distribution

of its assets (or rights to acquire its assets) to all holders of shares of Common Stock, by way of return of capital or otherwise (including,

without limitation, any distribution of cash, stock or other securities, property, options, evidence of indebtedness or any other assets

by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction, but, for

the avoidance of doubt, excluding any distribution of shares of Common Stock subject to Section 9(a), any distribution of Purchase

Rights (as defined below) subject to Section 9(c) and any Fundamental Transaction (as defined below) subject to Section 9(d))

(a “Distribution”) then, in each such case, the Holder shall be entitled to participate in such Distribution to the

same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon

complete exercise of this Warrant (without regard to any limitations or restrictions on exercise of this Warrant, including without limitation,

the Maximum Percentage (as defined below)) immediately before the date on which a record is taken for such Distribution, or, if no such

record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such

Distribution; provided, that to the extent that the Holder’s right to participate in any such Distribution would

result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, then the Holder shall not be entitled to participate

in such Distribution to such extent (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of

such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until

such time or times as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage,

at which time or times the Holder shall be granted such Distribution (and any Distributions declared or made on such initial Distribution

or on any subsequent Distribution held similarly in abeyance) to the same extent as if there had been no such limitation.

Rights. If at any time on or after the Original Issue Date, the Company grants, issues or sells any Options, Convertible Securities

or rights to purchase stock, warrants, securities or other property, in each case pro rata to all of the record holders of any class

of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to

such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares

of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations or restrictions on exercise of this

Warrant, including without limitation, the Maximum Percentage) immediately before the date on which a record is taken for the grant,

issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common Stock are

to be determined for the grant, issuance or sale of such Purchase Rights; provided, that to the extent that the Holder’s

right to participate in any such Purchase Right would result in the Holder and the other Attribution Parties exceeding the Maximum Percentage,

then the Holder shall not be entitled to participate in such Purchase Right to such extent (and shall not be entitled to beneficial ownership

of such Common Stock as a result of such Purchase Right (and beneficial ownership) to such extent) and at the Holder’s election,

in its sole discretion, either (1) such Purchase Right to such extent shall be held in abeyance for the benefit of the Holder until such

time or times as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage,

at which time or times the Holder shall be granted such right (and any Purchase Right granted, issued or sold on such initial Purchase

Right or on any subsequent Purchase Right to be held similarly in abeyance) to the same extent as if there had been no such limitation)

or (2) the Company shall offer the Holder the right upon exercise of such Purchase Right to acquire a security (e.g. a pre-funded warrant)

that would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage but will otherwise to the extent

possible have economic and other rights, preferences and privileges substantially consistent and on par with the securities or other

property issuable upon exercise of the originally offered Purchase Rights. As used in this Section 9(c), (i) “Options”

means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities and (ii) “Convertible

Securities” mean any stock or securities (other than Options) directly or indirectly convertible into or exercisable or exchangeable

for shares of Common Stock.

(d) Fundamental

Transactions. If, at any time while this Warrant is outstanding (i) the Company, directly or indirectly (including through any subsidiary

of the Company) effects any merger or consolidation of the Company with or into another Person, in which the Company is not the surviving

entity or in which the stockholders of the Company immediately prior to such merger or consolidation do not own, directly or indirectly,

at least 50% of the voting power of the surviving entity immediately after such merger or consolidation, (ii) the Company effects any

sale to another Person of all or substantially all of its assets in one or a series of related transactions, (iii) pursuant to any tender

offer or exchange offer (whether by the Company or another Person), holders of capital stock tender shares representing more than 50%

of the voting power of the capital stock of the Company and the Company or such other Person, as applicable, accepts such tender for

payment, (iv) the Company consummates a stock purchase agreement or other business combination (including, without limitation, a reorganization,

recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the voting

power of the capital stock of the Company (except for any such transaction in which the stockholders of the Company immediately prior

to such transaction maintain, in substantially the same proportions, the voting power of such Person immediately after the transaction)

or (v) the Company effects any reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock

is effectively converted into or exchanged for other securities, cash or property (other than as a result of a subdivision or combination

of shares of Common Stock covered by Section 9(a) above) (in any such case, a “Fundamental Transaction”), then

following such Fundamental Transaction the Holder shall have the right to receive, upon exercise of this Warrant, the same amount and

kind of securities, cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction if

it had been, immediately prior to such Fundamental Transaction, the holder of the number of Warrant Shares then issuable upon exercise

in full of this Warrant (including any Distributions or Purchase Rights then held in abeyance pursuant to Sections 9(b) or 9(c)

above) without regard to any limitations on exercise contained herein (the “Alternate Consideration”). If holders

of Common Stock are given any choice as to the securities, cash or other property to be received in a Fundamental Transaction, then the

Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such

Fundamental Transaction. The Company shall not effect any Fundamental Transaction in which the Company is not the surviving entity or

the Alternate Consideration includes securities of another Person unless (i) the Alternate Consideration is solely cash and the Company

provides for the simultaneous “cashless exercise” of this Warrant pursuant to Section 10 below or (ii) prior to or

simultaneously with the consummation thereof, any successor to the Company, surviving entity or other Person (including any purchaser

of assets of the Company) shall assume the obligation to deliver to the Holder such Alternate Consideration as, in accordance with the

foregoing provisions, the Holder may be entitled to receive, and the other obligations under this Warrant. The provisions of this paragraph

(d) shall similarly apply to subsequent transactions analogous to a Fundamental Transaction type. If the Company undertakes a Fundamental

Transaction in which the Company is not the surviving entity and the Alternate Consideration includes securities of another Person, then

the Company shall provide that, prior to or simultaneously with the consummation of such Fundamental Transaction, any successor to the

Company, surviving entity or other Person (including any purchaser of assets of the Company) shall assume the obligation to deliver to

the Holder such Alternate Consideration as the Holder is entitled to receive in accordance with the foregoing provisions, and to assume

the other obligations under this Warrant. The provisions of this paragraph (d) shall similarly apply to subsequent transactions

analogous of a Fundamental Transaction type. The Company shall cause any successor entity in a Fundamental Transaction in which the Company

is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this

Warrant in accordance with the provisions of this Section 9(d) pursuant to written agreements in form and substance reasonably

satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at

the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written

instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital

stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise

of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an

exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value

of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such adjustments

to the number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant

immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to

the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for the

Company (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the “Company”

shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations

of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein. Notwithstanding

the foregoing, and without limiting Section 11 hereof, the Holder may elect, at its sole option, by delivery of written notice

to the Company to waive this Section 9(d) to permit a Fundamental Transaction without the assumption of this Warrant.

(e) Number

of Warrant Shares. Simultaneously with any adjustment to the Number of Warrant Shares pursuant to Section 9, the Exercise

Price shall be increased or decreased proportionately, so that after such adjustment the aggregate Exercise Price payable hereunder for

the increased or decreased Number of Warrant Shares shall be the same as the aggregate Exercise Price in effect immediately prior to

such adjustment. Notwithstanding the foregoing, in no event may the Exercise Price be adjusted below the par value of the Common Stock

then in effect.

(f) Calculations.

All calculations under this Section 9 shall be made to the nearest one-tenth of one cent or the nearest share, as applicable.

(g) Notice

of Adjustments. Upon the occurrence of each adjustment pursuant to this Section 9, the Company at its expense will, at the

written request of the Holder, promptly compute such adjustment, in good faith, in accordance with the terms of this Warrant and prepare

a certificate setting forth such adjustment, including a statement of the adjusted Exercise Price and adjusted number or type of Warrant

Shares or other securities issuable upon exercise of this Warrant (as applicable), describing the transactions giving rise to such adjustments

and showing in detail the facts upon which such adjustment is based. Upon written request, the Company will promptly deliver a copy of

each such certificate to the Holder and to the Company’s transfer agent.

(h) Notice

of Corporate Events. If, while this Warrant is outstanding, the Company (i) declares a dividend or any other distribution of cash,

securities or other property in respect of its Common Stock, including, without limitation, any granting of rights or warrants to subscribe

for or purchase any capital stock of the Company or any subsidiary, (ii) authorizes or approves, enters into any agreement contemplating

or solicits stockholder approval for any Fundamental Transaction or (iii) authorizes the voluntary dissolution, liquidation or winding

up of the affairs of the Company, then the Company shall deliver to the Holder a notice of such transaction at least ten (10) days prior

to the applicable record or effective date on which a Person would need to hold Common Stock in order to participate in or vote with

respect to such transaction; provided, however, that the failure to deliver such notice or any defect therein shall not affect the validity

of the corporate action required to be described in such notice. In addition, if while this Warrant is outstanding, the Company authorizes

or approves, enters into any agreement contemplating or solicits stockholder approval for any Fundamental Transaction contemplated by

Section 9(d), other than a Fundamental Transaction under clause (iii) of Section 9(d), the Company shall deliver to the

Holder a notice of such Fundamental Transaction at least thirty (30) days prior to the date such Fundamental Transaction is consummated.

Holder agrees to maintain any information disclosed pursuant to this Section 9(h) in confidence until such information is publicly

available, and shall comply with applicable law with respect to trading in the Company’s securities following receipt of any such

information.

(i) Voluntary

Adjustment By Company. Subject to the rules and regulations of the Principal Trading Market, the Company may at any time during the

term of this Warrant, reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board

of directors of the Company.

10. Payment

of Exercise Price. Notwithstanding anything contained herein to the contrary, if at any time of exercise hereof, there is no

effective registration statement registering, or the prospectus contained therein is not available for the resale of, the Warrant Shares

by the Holder, then the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a “cashless

exercise”, in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected

pursuant to Section 3(a)(9) of the Securities Act, determined as follows:

= Y [(A-B)/A]

where:

“X” equals

the number of Warrant Shares to be issued to the Holder;

“Y” equals

the total number of Warrant Shares with respect to which this Warrant is then being exercised;

“A” equals

the Closing Sale Price of the shares of Common Stock (as reported by Bloomberg Financial Market) as of the Trading Day on the date immediately

preceding the Exercise Date; and

“B” equals

the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.

For

purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued

in a “cashless exercise” transaction shall be deemed to have been acquired by the Holder, and the holding period for the

Warrant Shares shall be deemed to have commenced, on the Original Issue Date (provided that the Commission continues to take the position

that such treatment is proper at the time of such exercise). If the Warrant Shares are issued in such a cashless exercise, the Company

acknowledges and agrees that, in accordance with Section 3(a)(9) of the Securities Act, the Exercise Shares issued in such exercise shall

take on the registered characteristics of the Warrants being exercised and may be tacked on to the holding period of the Warrants being

exercised. Without limiting any rights of the Holder to receive Warrant Shares on a “cashless exercise” pursuant to this

Section 10 or to receive a cash payment as set forth in Section 12 (No Fractional Shares), in no event shall the Company be required

to net cash settle an exercise of this Warrant.

11. Limitations

on Exercise.

(a) Notwithstanding

anything to the contrary contained herein, the Company shall not effect the exercise of any portion of this Warrant, and the Holder of

this Warrant shall not have the right to exercise any portion of the Warrant, and any such exercise shall be null and void ab initio

and treated as if the exercise had not been made, to the extent that immediately prior to or following such exercise, the Holder, together

with the Attribution Parties, beneficially owns or would beneficially own as determined in accordance with Section 13(d) of the Exchange

Act and the rules promulgated thereunder, in excess of 4.99% (the “Maximum Percentage”) of the Common Stock that would

be issued and outstanding following such exercise. For purposes of calculating beneficial ownership for determining whether the Maximum

Percentage is or will be exceeded, the aggregate number of shares of Common Stock held and/or beneficially owned by the Holder together

with the Attribution Parties, shall include the number of shares of Common Stock held and/or beneficially owned by the Holder together

with the Attribution Parties plus the number of shares of Common Stock issuable upon exercise of the relevant Warrant with respect to

which the determination is being made but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise

of the remaining, unexercised Warrant held and/or beneficially owned by the Holder or the Attribution Parties and (ii) exercise or conversion

of the unexercised or unconverted portion of any other securities of the Company held and/or beneficially owned by such Holder or any

Attribution Party (including, without limitation, any convertible notes, convertible stock or warrants) that are subject to a limitation

on conversion or exercise analogous to the limitation contained herein. For purposes of this Paragraph 11(a), beneficial ownership

of the Holder or the Attribution Parties shall, except as set forth in the immediately preceding sentence, be calculated and determined

in accordance with Section 13(d) of the Exchange Act and the rules promulgated thereunder. For purposes of this Warrant, in determining

the number of outstanding shares of Common Stock, a Holder of this Warrant may rely on the number of outstanding shares of Common Stock

as reflected in (1) the Company’s most recent Form 10-K, Form 10-Q, Current Report on Form 8-K or other public filing with the

Securities and Exchange Commission, as the case may be, (2) a more recent public announcement by the Company or (3) any other notice

by the Company or the Company’s transfer agent setting forth the number of shares of Common Stock outstanding (such issued and

outstanding shares, the “Reported Outstanding Share Number”). For any reason at any time, upon the written or oral

request of the Holder, the Company shall within one (1) business day confirm orally and in writing or by electronic mail to the Holder

the number of shares of Common Stock then outstanding. Each delivery of an Exercise Notice by the Holder will constitute a representation

by the Holder, upon which the Company shall be entitled to rely without investigation, that the Holder has evaluated the limitation set

forth in this paragraph and determined that the issuance of the full number of Warrant Shares requested in such Exercise Notice is permitted

under this paragraph. In the event that the issuance of Common Stock to the Holder upon exercise of this Warrant results in the Holder,

together with the Attribution Parties, being deemed to beneficially own, in the aggregate, more than the Maximum Percentage of the number

of outstanding shares of Common Stock (as determined under Section 13(d) of the Exchange Act), the number of shares so issued by which

the Holder’s, together with the Attribution Parties’, aggregate beneficial ownership exceeds the Maximum Percentage (the

“Excess Shares”) shall be deemed null and void and shall be cancelled ab initio, and the Holder and/or the Attribution

Parties shall not have the power to vote or to transfer the Excess Shares. As soon as reasonably practicable after the issuance of the

Excess Shares has been deemed null and void, the Company shall return to the Holder the exercise price paid by the Holder for the Excess

Shares. By written notice to the Company, a Holder of this Warrant may from time to time increase or decrease the Maximum Percentage

to any other percentage not in excess of 19.99% specified in such notice; provided that any increase in the Maximum Percentage will not

be effective until the 61st day after such notice is delivered to the Company and shall not negatively affect any partial exercise effected

prior to such change.

(b) This

Section 11 shall not restrict the number of shares of Common Stock which a Holder or the Attribution Parties may receive or beneficially

own in order to determine the amount of securities or other consideration that such Holder or the Attribution Parties may receive in

the event of a Fundamental Transaction as contemplated in Section 9(c) of this Warrant. For purposes of clarity, the shares of

Common Stock issuable pursuant to the terms of this Warrant in excess of the Maximum Percentage shall not be deemed to be beneficially

owned by the Holder or the Attribution Parties for any purpose including for purposes of Section 13(d) of the Exchange Act and the rules

promulgated thereunder or Section 16 of the Exchange Act and the rules promulgated thereunder, including Rule 16a-1(a)(1). No prior inability

to exercise this Warrant pursuant to this paragraph shall have any effect on the applicability of the provisions of this paragraph with

respect to any subsequent determination of exercisability. The provisions of this paragraph shall be construed and implemented in a manner

otherwise than in strict conformity with the terms of this Section 11 to the extent necessary to correct this paragraph or any

portion of this paragraph which may be defective or inconsistent with the intended beneficial ownership limitation contained in this

Section 11 or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitation

contained in this paragraph may not be waived and shall apply to a successor holder of this Warrant.

12. No

Fractional Shares. No fractional Warrant Shares will be issued in connection with any exercise of this Warrant. In lieu of any

fractional shares that would otherwise be issuable, the number of Warrant Shares to be issued shall be rounded down to the next whole

number and the Company shall pay the Holder in cash the fair market value (based on the Closing Sale Price) for any such fractional shares.

13. Notices.

Any and all notices or other communications or deliveries hereunder (including, without limitation, any Exercise Notice) shall be in

writing and shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered

confirmed e-mail at the e-mail address specified in the books and records of the Transfer Agent prior to 5:30 P.M., New York City time,

on a Trading Day, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via confirmed

e-mail at the e-mail address specified in the books and records of the Transfer Agent on a day that is not a Trading Day or later than

5:30 P.M., New York City time, on any Trading Day, (iii) the Trading Day following the date of mailing, if sent by nationally recognized

overnight courier service specifying next business day delivery, or (iv) upon actual receipt by the Person to whom such notice is required

to be given, if by hand delivery.

14. Warrant

Agent. The Company shall initially serve as warrant agent under this Warrant. Upon 30 days’ notice to the Holder, the Company

may appoint a new warrant agent. Any corporation into which the Company or any new warrant agent may be merged or any corporation resulting

from any consolidation to which the Company or any new warrant agent shall be a party or any corporation to which the Company or any

new warrant agent transfers substantially all of its corporate trust or shareholders services business shall be a successor warrant agent

under this Warrant without any further act. Any such successor warrant agent shall promptly cause notice of its succession as warrant

agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder’s last address as shown on the Warrant Register.

15. Miscellaneous.

(a) No

Rights as a Stockholder. Except as otherwise set forth in this Warrant, the Holder, solely in such Person’s capacity as a holder

of this Warrant, shall not be entitled to vote or be deemed the holder of share capital of the Company for any purpose, nor shall anything

contained in this Warrant be construed to confer upon the Holder, solely in such Person’s capacity as the Holder of this Warrant,

any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any

reorganization, issue of stock, reclassification of stock, consolidation, merger, amalgamation, conveyance or otherwise), receive notice

of meetings, or otherwise, prior to the issuance to the Holder of the Warrant Shares which such Person is then entitled to receive upon

the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the

Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities

are asserted by the Company or by creditors of the Company.

(b) Further

Assurances. Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without

limitation, amending its certificate or articles of incorporation or through any reorganization, transfer of assets, consolidation, merger,

dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of

the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all

such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without

limiting the generality of the foregoing, the Company will (a) not increase the par value of any Warrant Shares above the amount payable

therefor upon such exercise immediately prior to such increase in par value, (b) take all such action as may be necessary or appropriate

in order that the Company may validly and legally issue fully paid and non-assessable Warrant Shares upon the exercise of this Warrant,

and (c) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body

having jurisdiction thereof as may be necessary to enable the Company to perform its obligations under this Warrant. Before taking any

action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,

the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory

body or bodies having jurisdiction thereof.

and Assigns. Subject to compliance with applicable securities laws, this Warrant may be assigned by the Holder. This Warrant may

not be assigned by the Company without the written consent of the Holder, except to a successor in the event of a Fundamental Transaction.

This Warrant shall be binding on and inure to the benefit of the Company and the Holder and their respective successors and assigns.

Subject to the preceding sentence, nothing in this Warrant shall be construed to give to any Person other than the Company and the Holder

any legal or equitable right, remedy or cause of action under this Warrant. This Warrant may be amended only in writing signed by the

Company and the Holder, or their successors and assigns.

(d) Amendment

and Waiver. Except as otherwise provided herein, the provisions of this Warrant may be amended and the Company may take any action

herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained the written consent

of the Holder.

(e) Acceptance.

Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions contained herein.

(f) Governing

Law; Jurisdiction. ALL QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS WARRANT SHALL BE GOVERNED

BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAW

THEREOF TO THE EXTENT THEY WOULD RESULT IN THE APPLICATION OF THE LAWS OF ANY OTHER JURISDICTION. EACH OF THE COMPANY AND THE HOLDER

HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE CITY OF NEW YORK, BOROUGH OF

MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR WITH ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED

HEREIN (INCLUDING WITH RESPECT TO THE ENFORCEMENT OF ANY OF THE TRANSACTION DOCUMENTS), AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT

TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT. EACH

OF THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH

SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF VIA REGISTERED OR CERTIFIED MAIL OR OVERNIGHT DELIVERY (WITH EVIDENCE OF DELIVERY)

TO SUCH PERSON AT THE ADDRESS IN EFFECT FOR NOTICES TO IT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF

PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED

BY LAW. EACH OF THE COMPANY AND THE HOLDER HEREBY WAIVES ALL RIGHTS TO A TRIAL BY JURY.

(g) Headings.

The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit or affect any

of the provisions hereof.

(h) Severability.

If any part or provision of this Warrant is held unenforceable or in conflict with the applicable laws or regulations of any jurisdiction,

the invalid or unenforceable part or provisions shall be replaced with a provision which accomplishes, to the extent possible, the original

business purpose of such part or provision in a valid and enforceable manner, and the remainder of this Warrant shall remain binding

upon the parties hereto.

(i) Remedies.

The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific

performance by the Company of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation

for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the

defense in any action for specific performance that a remedy at law would be adequate.

(j) Entire

Agreement. This Warrant, together with the Purchase Agreement, constitutes the entire agreement between the Company and the Holder

with respect to the Warrant.

[REMAINDER

OF PAGE INTENTIONALLY LEFT BLANK]

WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by its authorized officer as of the date first indicated above.

THE

ELMET GROUP CO.

By:

/s/

Peter V. Anania

Name:

Peter

V. Anania

Title:

Chief

Executive Officer and Chairman

SCHEDULE

FORM

OF EXERCISE NOTICE

[To

be executed by the Holder to purchase shares of Common Stock under the Warrant]

Ladies

and Gentlemen:

(1)

The undersigned is the Holder of Warrant No. __ (the “Warrant”) issued by The Elmet Group Co., a Delaware corporation (the

“Company”). Capitalized terms used herein and not otherwise defined herein have the respective meanings set forth in the

Warrant.

(2)

The undersigned hereby exercises its right to purchase _____ Warrant Shares pursuant to the Warrant.

(3)

The Holder intends that payment of the Exercise Price shall be made as (check one):

☐

Cash

Exercise

☐

“Cashless

Exercise” under Section 10 of the Warrant

(4)

If the Holder has elected a Cash Exercise, the Holder shall pay the sum of $ _____ in immediately available funds to the Company in accordance

with the terms of the Warrant.

(5)

Pursuant to this Exercise Notice, the Company shall deliver to the Holder Warrant Shares determined in accordance with the terms of the

Warrant.

(6)

By its delivery of this Exercise Notice, the undersigned represents and warrants to the Company that in giving effect to the exercise

evidenced hereby (i) the Holder is an “accredited investor” as defined in Regulation D promulgated under the Securities Act

of 1933, as amended and (ii) the Holder will not beneficially own in excess of the number of shares of Common Stock (as determined in

accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended) permitted to be owned under Section 11(a)

of the Warrant to which this notice relates.

Dated:

Name

of Holder:

By:

Name:

Title:

(Signature

must conform in all respects to name of Holder as specified on the face of the Warrant)

EX-10.1 — WARRANT PURCHASE AGREEMENT, DATED SEPTEMBER 21, 2026, BY AND BETWEEN THE ELMET GROUP CO. AND BLUE MOON METALS INC

EX-10.1

Filename: ea030613001ex10-1.htm · Sequence: 3

Exhibit 10.1

WARRANT PURCHASE AGREEMENT

This WARRANT PURCHASE AGREEMENT

(this “Agreement”), is made and entered into as of September 21, 2026, by and between The Elmet Group Co., a

Delaware corporation, having an address at 280 Fore Street, Suite 301, Portland, Maine 04101 (the “Company”),

and Blue Moon Metals Inc., a company existing under the laws of British Columbia (the “Purchaser”).

RECITALS

WHEREAS, the Company desires

to issue and sell to the Purchaser, and the Purchaser desires to acquire from the Company, a warrant to purchase shares of common stock

of the Company, par value $0.001 per share (the “Common Stock”), upon the terms and subject to the conditions

set forth herein, as consideration for the Purchaser’s substantially contemporaneous entry into, and agreement to perform its obligations

under, a binding letter agreement with the Company (the “Letter Agreement”) providing for certain transactions

contemplated thereby, including the Purchaser’s investment in the Company as contemplated thereby (collectively, the “Purchaser

Consideration”), it being understood and agreed that no separate cash purchase price or other consideration shall be payable

by the Purchaser to the Company solely for the issuance and sale of the warrant (the “Offering”);

WHEREAS, the Company and the

Purchaser are each executing and delivering this Agreement in reliance upon the exemption from registration afforded by Section 4(a)(2)

of the Securities Act and Rule 506 of Regulation D promulgated thereunder.

NOW, THEREFORE, in consideration

of the premises and the respective representations, warranties, covenants and agreements herein contained and for other good and valuable

consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:

ARTICLE

DEFINITIONS

1.1. Certain

Defined Terms. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, and unless the context

requires a different meaning, the following terms shall have the following meanings:

“Action”

means any notice of noncompliance or violation, or any claim, demand, charge, action, suit, litigation, audit, settlement, complaint,

stipulation, assessment or arbitration, or any request (including any request for information), review, inquiry, hearing, proceeding or

investigation, an opposition, revocation, reexamination, interference or similar proceeding by

any Person or by or before any Governmental Authority.

“Affiliate”

is a Person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control

with, the Person specified.

“Board of Directors”

means the board of directors of the Company.

“Business Day”

means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by

law to remain closed; provided, however, for clarification, commercial banks shall

not be deemed to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”,

“non-essential employee” or any other similar orders or restrictions or the closure of any physical branch locations

at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial

banks in The City of New York are generally open for use by customers on such day.

“Closing”

means the closing of the issuance and sale of the Warrant pursuant to Section 2.1.

“Closing Date”

means the day on which this Agreement and the Warrant have been executed and delivered.

“Contract”

means any contract, agreement, binding arrangement, commitment or understanding, bond, note, indenture, mortgage, debt instrument, license

(or any other contract, agreement or binding arrangement concerning Intellectual Property), franchise, lease or other instrument or obligation

of any kind, written or oral (including any amendments or other modifications thereto).

“Exchange Act” means

the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated by the SEC thereunder.

“GAAP”

means United States generally accepted accounting principles applied on a consistent basis.

“Governmental Authority”

means any foreign, federal or national, state or provincial, municipal or local government, governmental authority, regulatory or administrative

agency, governmental commission, department, board, bureau, agency or instrumentality, political subdivision, court, tribunal, official

arbitrator or arbitral body or any securities exchange, in each case whether domestic or foreign.

“Intellectual Property”

means all of the following as they exist in any jurisdiction throughout the world: (a) Patents; (b) trademarks; (c) copyrights; (d) trade

secrets and other confidential or proprietary business information, including concepts, ideas, designs, research or development information,

processes, procedures, techniques, technical information, specifications, operating and maintenance manuals, drawings, methods, know-how,

data, formulas, compositions, and methods, technical data, customer and supplier lists, pricing and cost information, and business and

marketing plans and proposals, discoveries, inventions, modifications, extensions, improvements, and other proprietary rights (whether

or not patentable or subject to copyright, trademark, or trade secret protection); (e) all domain name and domain name registrations,

web sites and web pages and related rights, registrations, items and documentation related thereto; (f) software; (g) rights of publicity

and privacy, and moral rights, and (h) all licenses, sublicenses, permissions, and other agreements related to the preceding property.

“Knowledge”

means: (i) with respect to the Company, the knowledge of a particular matter by an officer of the Company (“Officer”)

in each case after due inquiry under the circumstances; (ii) with respect to each Officer, the knowledge of a particular matter by such

Officer, in each case after due inquiry under the circumstances; and (iii) with respect to the Purchaser, the actual present knowledge

of a particular matter by any of the directors or executive officers of the Purchaser, as applicable, without any duty of inquiry.

“Law”

means any federal, state, local, municipal, foreign or other law, statute, legislation, principle of common law, ordinance, code, edict,

decree, proclamation, treaty, convention, rule, regulation, directive, requirement, writ, injunction, settlement, Permit or Order that

is or has been issued, enacted, adopted, passed, approved, promulgated, made, implemented or otherwise put into effect by or under the

authority of any Governmental Authority.

“Liabilities”

means any and all debts, liabilities and obligations of any nature whatsoever, whether accrued or fixed, absolute or contingent, mature

or unmatured or determined or determinable, including those arising under any Law, Action, Order or Contract.

“Lien”

means any interest (including any security interest), pledge, mortgage, lien, encumbrance, charge, claim or other right of third parties,

whether created by law or in equity, including any such restriction on the use, voting, transfer, receipt of income or other exercise

of any attributes of ownership.

“Material Adverse

Effect” means, with respect to either the Purchaser or the Company, as applicable, any event, fact, condition, change, circumstance,

occurrence or effect, which, either individually or in the aggregate with all other events, facts, conditions, changes, circumstances,

occurrences or effects, (a) that has a material adverse effect on the business, properties, assets, Liabilities, condition (financial

or otherwise), operations, licenses or other franchises or results of operations of business, or materially diminish the value of the

business or its assets or materially increase the liabilities or (b) that materially impairs or delays the ability of the Company or the

Purchaser, as applicable, to perform its respective obligations under this Agreement or any other Transaction Document or to consummate

the transactions contemplated hereby and thereby; provided, however, that a Material Adverse Effect will not include any

adverse effect or change resulting from any change, circumstance or effect relating to (i) the economy in general, (ii) securities markets,

regulatory or political conditions in the United States (including terrorism or the escalation of any war, whether declared or undeclared

or other hostilities), (iii) changes in applicable Laws or GAAP or the application or interpretation thereof, (iv) the industry in which

the Company’s or the Company’s business operates and not specifically relating to the business or (v) a natural disaster (provided,

that in the cases of clauses (i) through (v), the Company’s or the Purchaser’s business, as applicable, is not disproportionately

affected by such event as compared to other similar companies and businesses in similar industries and geographic regions as the Company’s

or the Purchaser’s business, as applicable).

“Nasdaq”

means The Nasdaq Stock Market.

“Order”

means any order, writ, rule, judgment, injunction, decree, stipulation, determination or award entered by or with any Governmental Authority.

“Patents”

means all patents, patent applications and the inventions, designs and improvements described and claimed therein, patentable inventions,

and other patent rights (including any divisionals, continuations, continuations-in-part, substitutions, or reissues thereof, whether

or not patents are issued on any such applications and whether or not any such applications are amended, modified, withdrawn, or refiled).

“Permit”

means any federal, state, local, foreign or other third-party permit, grant, easement, consent, approval, authorization, exemption, license,

franchise, concession, ratification, permission, clearance, confirmation, endorsement, waiver, certification, designation, product registration,

rating, registration or qualification that is or has been issued, granted, given or otherwise made available by or under the authority

of any Governmental Authority or other Person.

“Permitted Exceptions”

means bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting the enforcement of creditors’ rights generally

and general principles of equity (regardless of whether enforceability is considered in a proceeding at law or in equity).

“Person”

shall include any individual, trust, firm, corporation, limited liability company, partnership, Governmental Authority or other entity

or association, whether acting in an individual, fiduciary or any other capacity.

“Representatives”

means, as to any Person, such Person’s Affiliates and its and their managers, directors, officers, employees, agents and advisors

(including financial advisors, counsel and accountants).

“SEC”

means the U.S. Securities and Exchange Commission.

“Securities”

means the Warrants and the Warrant Shares.

“Securities Act”

means the U.S. Securities Act of 1933, as amended, and the rules and regulations promulgated by the SEC thereunder.

“Tax”

means any applicable federal, state, local or foreign income, gross receipts, license, payroll, parking, employment, excise, severance,

stamp, occupation, premium, windfall profits, environmental, natural resources, customs duties, capital stock, franchise, profits, withholding,

social security (or similar), payroll, unemployment, disability, real property, personal property, sales, use, transfer, registration,

value added, alternative or add-on minimum, estimated tax, or other tax of any kind whatsoever, including any interest, penalty, or addition

thereto, whether disputed or not, including such item for which Liability arises from the application of Treasury Regulation 1.1502-6,

as a transferee or successor-in-interest, by contract or otherwise, and any Liability assumed or arising as a result of being, having

been, or ceasing to be a member of any affiliated group (as defined in Section 1504(a) of the U.S. Internal Revenue Service Code) (or

being included or required to be included in any tax return relating thereto) or as a result of any Tax indemnity, Tax sharing, Tax allocation

or similar Contract.

“Third

Party” shall mean any Person that is not a party to this Agreement or an Affiliate of a party to this Agreement.

“Transaction

Documents” mean this Agreement, the Warrant and all schedules, exhibits and appendices attached to hereto and thereto.

“Warrant”

means, collectively, the warrant to purchase shares of Common Stock delivered to the Purchaser at the Closing in accordance with Section

2.2 hereof, which Warrant shall be exercisable six (6) months following the Closing Date and have a term of exercise equal to three (3)

years, in the form of Exhibit A attached hereto.

“Warrant

Shares” means the shares of Common Stock issuable upon exercise of the Warrant.

ARTICLE

ISSUANCE aND SALE

2.1. Closing.

On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery

of this Agreement by the parties hereto, the Company hereby agrees to issue and sell to the Purchaser, and the Purchaser hereby agrees

to accept and acquire from the Company, a Warrant to purchase up to 1,166,970 shares of Common Stock at an exercise price of $21.423

per Warrant Share. The Warrant is being issued and sold to the Purchaser in exchange for the Purchaser Consideration. The Company shall

deliver to the Purchaser the Warrant, as determined pursuant to Section 2.2(a), and the Company and the Purchaser shall deliver the other

items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2

and 3, the Closing shall take place remotely by electronic transfer of the Closing documentation.

2.2. Deliveries.

(a) On

or prior to the Closing Date, the Company shall deliver or cause to be delivered to the Purchaser the following:

(i) this

Agreement duly executed by the Company;

(ii) a

Warrant registered in the name of the Purchaser to purchase up to 1,166,970 shares of Common Stock, with an exercise price equal to $21.423

per Warrant Share, subject to adjustment as provided therein;

(b) On

or prior to the Closing Date, the Purchaser shall deliver or cause to be delivered to the Company the following:

(i) this

Agreement duly executed by the Purchaser.

ARTICLE

III

CLosing conditions

3.1. Conditions

to Obligations of the Company. The obligations of the Company to consummate the transactions contemplated by this Agreement shall

be subject to the fulfillment or written waiver, at or prior to the Closing, of each of the following conditions:

(a) Representations,

Warranties and Covenants. The representations and warranties of the Purchaser shall be true and correct in all material respects as

of each date when made and as of the Closing Date, as though made at that time (except for representations and warranties that speak as

of a specific date, which shall be true and correct in all material respects as of such specific date), and the Purchaser shall have performed,

satisfied and complied in all material respects with the covenants, agreements and conditions required by this Agreement to be performed,

satisfied or complied with by the Purchaser at or prior to the Closing Date;

(b) No

Order. No Governmental Authority shall have enacted, issued, promulgated, enforced or entered any Law or Order (whether temporary,

preliminary or permanent) that has the effect of making the transactions contemplated by the Transaction Documents illegal or otherwise

restraining or prohibiting the consummation of such transactions; and

All authorizations, approvals or permits, if any, of any Governmental Authority or regulatory body of the United States or of any state

that are required in connection with the lawful issuance and sale of the Warrant pursuant to this Agreement shall be obtained and effective

as of the Closing.

3.2. Conditions

to Obligations of the Purchaser. The obligations of the Purchaser to consummate the transactions contemplated by this Agreement shall

be subject to the fulfillment or written waiver, at or prior to the Closing, of each of the following conditions:

(a) Representations

and Warranties. The representations and warranties of the Company shall be true and correct in all material respects as of the date

when made and as of Closing Date as though made at such time (except for representations and warranties that speak as of a specific date,

which shall be true and correct in all material respects as of such specific date) and the Company shall have performed, satisfied and

complied in all material respects with the covenants, agreements and conditions required by this Agreement to be performed, satisfied

or complied with by the Company at or prior to the Closing Date.

(b) No

Order. No Governmental Authority shall have enacted, issued, promulgated, enforced or entered any Law or Order (whether temporary,

preliminary or permanent) that has the effect of making the transactions contemplated by the Transaction Documents illegal or otherwise

restraining or prohibiting the consummation of such transactions;

Material Adverse Effect. There shall not have occurred prior to the Closing any event or transaction reasonably likely to have a Material

Adverse Effect.

(d) Listing

Requirements. No stop order or suspension of trading shall have been imposed by Nasdaq, the SEC or any other Governmental Authority

with respect to public trading in the Common Stock. The Common Stock shall be listed on the Nasdaq Capital Market and shall not have been

suspended by the SEC or Nasdaq from trading thereon nor shall suspension by the SEC or Nasdaq have been threatened in writing by the SEC

or Nasdaq, and, if required by applicable Nasdaq rules, the Company shall have filed with Nasdaq a “Notification Form: Listing of

Additional Shares” for the listing of the Warrant Shares and Nasdaq shall have raised no objection to such notice or the transactions

contemplated hereby.

ARTICLE

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

The Company represents and warrants

to the Purchaser, as of the date of this Agreement and as of the Closing Date, as follows:

4.1. Organization.

The Company is a Delaware corporation duly organized, validly existing and in good standing under the laws of Delaware and has full corporate

power and authority to own, use and operate its assets and to conduct its business as and where it is being conducted.

4.2. Authorization.

The Company has full power and authority to enter into each of the Transaction Documents to which it is a party and to consummate the

transactions contemplated hereby and thereby and to perform its obligations hereunder and thereunder. The execution and delivery of the

Transaction Documents and the consummation of the transactions contemplated hereby and thereby have been duly authorized by Board of Directors’

action on the part of the Company, and no further corporate action is required by the Company, its Board of Directors or its stockholders

in connection therewith (including to effect the issuance of the Warrant). This Agreement and the Warrant have been duly executed and

delivered by the Company. This Agreement constitutes, and upon the execution and delivery thereof by the Company the Warrant will constitute,

a legal, valid and binding obligation of the Company, as applicable, enforceable against the Company, in accordance with their terms,

except as the enforceability thereof may be limited by the Permitted Exceptions.

4.3. Issuance

of the Securities. The Securities to be issued to the Purchaser pursuant to the Transaction Documents have been duly authorized. Upon

exercise of the Warrant in accordance with its terms and receipt of the Exercise Price contemplated therein, the Warrant Shares will be

issued and delivered in accordance with the terms of the Transaction Documents, and will be validly issued, fully paid and non-assessable,

and free and clear of any Taxes imposed in connection with such issuance. Assuming the accuracy of the representations and warranties

of the Purchaser in this Agreement, the Securities will be issued in compliance with, and without the need for registration or qualification

under, all applicable federal and state securities laws.

4.4. Compliance

with Laws. The Company is in compliance, and has complied, in all material respects with all Laws and Orders in respect of the ownership,

operation, use or possession of its assets and/or the conduct of its business. None of the ownership, operation, use or possession of

its assets or the conduct of the Company’s business conflicts with the rights of any other Person or violates, or with or without

the giving of notice or passage of time, or both, will violate, conflict with or result in a default, right to accelerate or loss of rights

under, any terms or provisions of any Lien, Contract or any Law or Order to which the Company is a party or by which any of its assets

or the Company’s business may be bound or affected. The Company has not received any written notice, order, complaint or other written

communication from any Governmental Authority that the Company is not in compliance in all material respects with any such Laws and Orders

with respect to the assets and/or the conduct of the Company’s business.

4.5. No

Conflict. The execution, delivery and performance of this Agreement and the Warrant by the Company, the issuance of the Securities

and the consummation of the other transactions contemplated hereby will not (i) violate any provision of the Certificate of Incorporation

or the Bylaws of the Company, each as amended to date, (ii) conflict with or result in any violation of or default (with or without notice

or lapse of time, or both) under, or give rise to a right of termination, cancellation or acceleration of any obligation, a change of

control right or to a loss of a benefit under any agreement or instrument, credit facility, franchise, license, judgment, order, statute,

law, ordinance, rule or regulations, applicable to the Company or its subsidiaries or their respective properties or assets, or (iii)

result in a violation of any Law or Order to which the Company or its securities are subject, or by which any property or asset of the

Company is bound or affected, in case of (ii) above, except as would not, individually or in the aggregate, be reasonably expected to

have a Material Adverse Effect.

4.6. Consents.

No consent, approval, authorization, filing with or order of or registration with, any court, governmental agency or body, and/or the

stockholders of the Company is required in connection with the transactions contemplated herein, except such as have been or will be obtained

or made under the Securities Act, and such as may be required under the securities, or blue sky, laws of any state or foreign jurisdiction

in connection with the offer and sale of the Securities by the Company in the manner contemplated herein.

4.7. SEC

Filings. The Company has timely filed all forms, statements, certifications, schedules, reports and documents required to be filed

by it with the SEC under Section 13, 14(a) and 15(d) of the Exchange Act for the one year preceding the date of this Agreement

or for such shorter period of time as it has been required to make such filings with the SEC under Section 13, 14(a) and 15(d) of the

Exchange Act. As of the time it was filed with the SEC (or, if amended or superseded by a filing prior to

the date of this Agreement, then on the date of such filing), each of the filed SEC Reports complied in all material respects with the

applicable requirements of the Exchange Act , and, as of the time they were filed , none of the filed SEC Reports contained any untrue

statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements

therein, in light of the circumstances under which they were made, not misleading.

4.8. Nasdaq

Stock Market. The issued and outstanding shares of Common Stock are registered pursuant to Section 12(b) of the Exchange Act and are

listed for trading on the Nasdaq Capital Market under the symbol “ELMT.” The Company is in compliance with all listing requirements

of Nasdaq applicable to the Company. There is no suit, action, proceeding or investigation pending or, to the knowledge of the Company,

threatened against the Company by Nasdaq or the SEC, respectively, to prohibit or terminate the listing of the Common Stock on the Nasdaq

Capital Market or to deregister the Common Stock under the Exchange Act. The Company has taken no action as of the date of this Agreement

that is designed to terminate the registration of the Common Stock under the Exchange Act.

4.9. Investment

Company Act. The Company is not, and immediately after receipt of payment for the Securities will not be, an “investment company”

within the meaning of the U.S. Investment Company Act of 1940, as amended.

ARTICLE

REPRESENTATIONS AND WARRANTIES OF THE PURCHASER

The Purchaser represents and

warrants to the Company as of the date of this Agreement and as of the Closing Date as follows:

5.1. Organization;

Authority. The Purchaser, is an entity duly organized, validly existing and in good standing under the Laws of the jurisdiction of

its formation and has all requisite power and authority to own, lease and operate its properties and to carry on its business as now being

conducted. The Purchaser has full corporate power and authority to enter into this Agreement and to consummate the transactions contemplated

hereby and thereby. The execution and delivery of this Agreement and the consummation of the transactions contemplated hereby have been

duly authorized by all necessary corporate action on the part of the Purchaser. This Agreement has been duly executed and delivered by

the Purchaser. This Agreement constitutes, and upon the execution and delivery thereof by the Purchaser, a legal, valid and binding obligation,

as applicable, enforceable against the Purchaser in accordance with its terms, except as the enforceability thereof may be limited by

the Permitted Exceptions.

5.2. No

Conflict. Neither the execution, delivery and performance of the Transaction Documents by the Purchaser, nor the consummation of the

transactions contemplated hereby or thereby, will violate or conflict with any (a) provision of the governing documents of the Purchaser,

(b) Law or Order to which the Purchaser is bound or subject, or (c) Contract or Permit to which the Purchaser is a party or by which Party

or the Purchaser may be bound or affected, in each of case of (i) through (iii) above, except as would not, individually or in the aggregate,

be reasonably expected to have a Material Adverse Effect.

5.3. Consents.

All consents, approvals, orders and authorizations required on the part of the Purchaser in connection with the execution, delivery or

performance of the Transaction Documents, the issuance of the Securities and the consummation of the other transactions contemplated hereby

and thereby have been obtained or made, other than such consents, approvals, orders and authorizations the failure of which to make or

obtain, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect.

5.4. No

Registration of the Securities. The Purchaser acknowledges that it is aware that (i) the Securities, are restricted securities and

have not been registered under the Securities Act and that the Securities cannot be and will not be sold unless they are subsequently

registered under the Securities Act or an exemption from such registration is available, (ii) the Securities have not been registered

or qualified under any applicable state law regulating securities and therefore the Securities cannot and will not be sold unless it is

subsequently registered or qualified under any such act or an exemption therefrom is available, (iii) except as otherwise set of forth

in this Agreement, neither the Company, nor any Representative of the Company has made any representation or warranty whatsoever as to

whether any exemption from the Securities Act, including, without limitation, any exemption for limited sales in routine brokers’

transactions pursuant to Rule 144 under the Securities Act is, or will become, available, and (iv) therefore, the Purchaser must agree

to bear the economic risk of investment for an indefinite period of time. The Purchaser acknowledges and agrees that the Securities shall

bear a restricted legend (the “Legend”), in the form and substance as set forth in Article VI hereof, prohibiting the

offer, sale, pledge or transfer of the Securities, except (i) pursuant to an effective registration statement filed under the Securities

Act, (ii) pursuant to an exemption from registration provided by Rule 144 under the Securities Act (if available), or (iii) pursuant to

any other exemption from the registration requirements of the Securities Act, and in each case in accordance with any applicable securities

laws of any state or any other jurisdiction.

5.5. Sophistication;

Economic Risk. The Purchaser represents and warrants that as of the date hereof it is, and on each date on which it exercises the

Warrant, it will be, (i) is an “accredited investor” as that term is defined in Rule 501(a) under Regulation D promulgated

pursuant to the Securities Act, and (ii) has such knowledge and experience in financial and business matters as to be able to protect

its own interests in connection with an investment in the Securities. The Purchaser further represents and warrants that (w) it is capable

of evaluating the merits and risk of an investment in the Company and has so evaluated the merits and risks of such investment, (x) that

it has not been organized for the purpose of acquiring the Securities, (y) it is able to bear the economic risk of an investment in the

Securities and, at the present time, is able to afford a complete loss of such investment and (z) that it is being represented in this

transaction by an attorney who is fully familiar with the securities laws affecting this transaction.

5.6. Intent.

The Purchaser is acquiring the Securities solely for investment purposes, for the Purchaser’s own account, and not with a view towards

the distribution or dissemination thereof in violation of the Securities Act. The Purchaser has no present arrangement to sell the Securities

to or through any person or entity. The Purchaser understands that the Securities must be held indefinitely unless such Securities are

resold pursuant to a registration statement under the Securities Act or an exemption from registration is available.

5.7. Independent

Investigation. The Purchaser, in making the decision to acquire the Securities, has relied upon an independent investigation of the

Company and has not relied upon any information or representations made by any third parties or upon any oral or written representations

or assurances from the Company, its officers, directors or employees or any other representatives or agents of the Company, other than

as set forth in this Agreement and the exhibits and schedules attached hereto. The Purchaser is familiar with the business, operations

and financial condition of the Company and has had an opportunity to ask questions of, and receive answers from, the Company’s officers

and directors concerning the Company and the terms and conditions of the offering of the Securities and has had full access to such other

information concerning the Company as the Purchaser has requested. Neither such inquiries nor any other due diligence investigation conducted

by the Company shall modify, limit or otherwise affect the Purchaser’s right to rely on the Company’s representations and

warranties contained in this Agreement.

5.8. General

Solicitation. The Purchaser is not, to the Purchaser’s Knowledge, purchasing the Securities as a result of any advertisement,

article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over

television or radio or presented at any seminar or, to the Knowledge of the Purchaser, any other general solicitation or general advertisement.

5.9. Reliance

on Advisors. Except for any statements or representations of the Company made in this Agreement, the Purchaser is relying solely on

its counsel and advisors and not on any statements or representations of the Company or any of its Representatives or agents for legal,

tax or investment advice with respect to this investment, the transactions contemplated by this Agreement or the securities laws of any

jurisdiction.

5.10. Reliance

on Representations and Warranties. The Purchaser understands that the Securities are being offered and sold to such Purchaser in reliance

on exemptions contained in specific provisions of United States federal securities laws and that the Company is relying upon the truth

and accuracy of the representations, warranties, agreements, acknowledgments and understandings of the Purchaser set forth in this Agreement

in order to determine the applicability of the exemptions contained in such provisions.

ARTICLE

Legends, etc.

6.1. Legend.

Each of the Securities shall be endorsed with the following legend, in addition to any other legend required to be placed thereon by applicable

federal or state securities laws:

“THIS SECURITY

HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION

FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED

OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR

IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES

LAWS.”

Upon request of the Purchaser, upon the earliest

of (i) the registration of the Securities for resale under an effective registration statement under the Securities Act, (ii) the resale

of the Securities pursuant to Rule 144, as set forth in customary documentation delivered by the Purchaser to the Company, (iii) the Securities

becoming eligible for resale under Rule 144(b)(1) (or any successor provision) without limitation, as set forth in a customary non-Affiliate

certificate delivered by the Purchaser to the Company, provided that a period of one year has passed from the Closing Date, and (iv) the

receipt by the Company of an opinion of counsel reasonably satisfactory to the Company to the effect that such legend is no longer required

under the Securities Act, the Company shall promptly cause the legend to be removed from any of the Securities; provided, that if the

Purchaser is an Affiliate (as determined in good faith by the Purchaser) and relying upon (iv) above, such legend will only be removed

upon a sale by such Purchaser. Any Securities subject to legend removal under this Section 6.1 shall, at the request of the Purchaser,

be transmitted to the Purchaser by crediting the account of the Purchaser’s prime broker. The Purchaser acknowledge that the Securities

have not been registered under the Securities Act or under any state securities laws and agree that they will not sell or otherwise dispose

of any of the Securities, except in compliance with the registration requirements or exemption provisions of the Securities Act and any

other applicable securities laws.

6.2. The

Purchaser’s Compliance. Nothing in this ARTICLE VI shall affect in any way the Purchaser’s obligations and agreement

to comply with all applicable securities laws upon resale of the Securities.

ARTICLE

VII

OTHER AGREEMENTS

7.1. Further

Assurances. In the event that at any time after the Closing Date any further action is reasonably necessary to carry out the purposes

of this Agreement, each of the parties will take such further action (including the execution and delivery of such further instruments

and documents) as the other parties reasonably may request, at the sole cost and expense of the requesting party(ies) (unless otherwise

specified herein or unless such requesting party(ies) is entitled to indemnification therefor under ARTICLE VIII in which case,

the costs and expense will be borne by the parties as set forth in ARTICLE VIII).

7.2. Confidentiality.

The Purchaser shall, and shall cause their respective Affiliates to: (a) treat and hold in strict confidence any confidential or proprietary

information relating to the information obtained from the Purchaser’s due diligence on the Company (“Confidential Information”),

and will not use for any purpose (other than for the Purchaser’s own benefit in connection with the transactions contemplated by

this Agreement and the other Transaction Documents), nor directly or indirectly disclose, distribute, publish, disseminate or otherwise

make available to any Third Party (other than its and its Affiliates’ Representatives, and any public relations firms that have

been engaged by the Purchaser or their Affiliates and that are subject to an obligation to keep such information confidential (“PR

Firms”)) any of the Confidential Information without the Company’s prior written consent; (b) in the event that any

of them becomes legally compelled to disclose any Confidential Information, to provide the Company, to the extent permitted by applicable

Law, with prompt written notice of such requirement so that the Company or an Affiliate thereof may seek a protective order or other remedy

or waive compliance with this Section 7.2; (c) in the event that such protective order or other remedy is not obtained, or the Company

waives compliance with this Section 7.2, to furnish only that portion of such Confidential Information which is legally required to be

provided as advised in writing by outside counsel and to exercise their commercially reasonable efforts to obtain assurances that confidential

treatment will be accorded such Confidential Information; (d) to the extent permitted by applicable Law, at the written request of the

Company, to promptly furnish (prior to, at, or as soon as practicable following, the Closing) to the Company any and all copies (in whatever

form or medium) of all such Confidential Information and to destroy any and all additional copies of such Confidential Information and

any analyses, compilations, studies or other documents prepared, in whole or in part, on the basis thereof; provided, however,

that Confidential Information shall not include any information which is, or becomes, generally available publicly and was not, and is

not, disclosed in breach of this Agreement by the Purchaser or its Affiliates. The Purchaser agrees and acknowledges that remedies at

law for any breach of its obligations under this Section 7.2 are inadequate and that in addition thereto the Company (or an Affiliate

thereof) shall be entitled to seek equitable relief, including injunction and specific performance, in the event of any such breach.

7.3. Publicity.

None of the parties hereto shall, and each party shall cause their respective Representatives not to, disclose, make or issue, any statement

or announcement concerning this Agreement or the transactions contemplated hereby (including the terms, conditions, status or other facts

with respect thereto) to any third parties (other than its Representatives who need to know such information in connection with carrying

out or facilitating the transactions contemplated hereby, and PR Firms) without the prior written consent of the other parties hereto

(such consent not to be unreasonably withheld, delayed or conditioned), except as required by applicable Law or any securities exchange

listing requirement. Notwithstanding the foregoing or anything else to the contrary contained herein, the parties acknowledge and agree

that each of the parties may (and is hereby permitted) issue a press release disclosing the terms of this Agreement and the Warrant, and

each of the parties hereby agrees to provide the other party with a reasonably opportunity to comment on any such press release and to

consider in good faith any such comments, and each party further agrees, to the extent reasonably practicable, to confer with the other

party regarding any other disclosure that may be required by applicable Law or any stock exchange listing requirement (except to the extent

such disclosure is materially consistent with, and not materially more extensive than, the disclosure contained in the initial press release

issued by such party).

ARTICLE

VIII

INDEMNIFICATION

8.1. Survival.

All representations and warranties of the Company and the Purchaser contained in this Agreement

(including all schedules and exhibit hereto and all certificates, documents, instruments and undertakings furnished pursuant to this Agreement)

shall survive the Closing indefinitely. All covenants, obligations and agreements of the parties contained in this Agreement (including

all schedules and exhibits hereto and all certificates, documents, instruments and undertakings furnished pursuant to this Agreement),

including any indemnification obligations, shall survive the Closing indefinitely and continue until fully performed in accordance with

their terms.

8.2. Indemnification

by the Company. Except as otherwise limited by this ARTICLE VIII, the Company shall indemnify, defend and hold harmless the

Purchaser, and its respective Affiliates, any assignee or successor thereof, and each officer, director, manager, employee, agent and

Representative of each of the foregoing (collectively, “Purchaser Indemnified Parties”, each of whom is an express

third party beneficiary of the applicable provisions of this Article VIII) from and against, and pay or reimburse the Purchaser Indemnified

Parties for, any and all losses, Actions, Orders, Liabilities, damages, diminution in value, taxes, interest, penalties, Liens, amounts

paid in settlement, costs and expenses (including reasonable expenses of investigation and court costs and reasonable attorneys’

fees and expenses), (any of the foregoing, a “Loss”) suffered or incurred by, or imposed upon, any Purchaser

Indemnified Party arising in whole or in part out of or resulting directly or indirectly from:

(a) any

breach of any representation, covenant, obligation or warranty of the Company in this Agreement; and

(b) enforcing

the Purchaser Indemnified Parties’ indemnification rights provided for hereunder.

8.3. Indemnification

by the Purchaser. Except as otherwise limited by this ARTICLE VIII, the Purchaser shall indemnify, defend and hold harmless

the Company, its respective Affiliates and each officer, manager, employee, agent and Representative of each of the foregoing (collectively,

the “Company Indemnified Parties”, each of whom is an express third party beneficiary of the applicable provisions

of this Article VIII) from and against, and pay or reimburse the Company Indemnified Parties for, any and all Losses, suffered or incurred

by, or imposed upon, any the Company Indemnified Party arising in whole or in part out of or resulting directly or indirectly from:

(a) any

breach of any representation, covenant, obligation or warranty of the Purchaser in this Agreement; and

(b) enforcing

the Company Indemnified Parties’ indemnification rights provided for hereunder.

8.4. Indemnification

Procedures.

(a) For

the purposes of this Agreement, (i) the term “Indemnitee” shall refer to the Person or Persons indemnified,

or entitled, or claiming to be entitled, to be indemnified, pursuant to the provisions of Section 8.2 or 8.3, as the case may be, and

(ii) the term “Indemnitor” shall refer to the Person or Persons having the obligation to indemnify pursuant

to such provisions.

(b) In

the case of any claim for indemnification under this Agreement arising from a claim of a Third Party (including any Governmental Authority),

an Indemnitee must give prompt written notice and, subject to the following sentence, in no case later than thirty (30) days after the

Indemnitee’s receipt of notice of such claim, to the Purchaser or the Company of any claim of which such Indemnitee has knowledge

and as to which it may request indemnification hereunder. The failure to give such notice will not, however, relieve an Indemnitor of

its indemnification obligations except to the extent that the Indemnitor is actually harmed thereby. The Indemnitor will have the right

to defend and to direct the defense against any such claim in its name and at its expense, and with counsel selected by the Indemnitor

unless (i) there is a conflict of interest between the Indemnitee and the Indemnitor in the conduct of such defense, (ii) the applicable

Third Party alleges claims of fraud, willful misconduct or intentional misrepresentation, or (iii) such claim is criminal in nature, could

reasonably be expected to lead to criminal proceedings, or seeks an injunction or other equitable relief against the Indemnitee. If the

Indemnitor elects, and is entitled, to compromise or defend such claim, it will within fifteen (15) days (or sooner, if the nature of

the claim so requires) notify the Indemnitee of its intent to do so, and the Indemnitee will, at the request and expense of the Indemnitor,

cooperate in the defense of such claim. If the Indemnitor elects not to, or is not entitled under this Section 8.4(b) to, compromise or

defend such claim, or fails to notify the Indemnitee of its election as herein provided, the Indemnitee may pay, compromise or defend

such claim. Notwithstanding anything to the contrary contained herein, the Indemnitor will have no indemnification obligations with respect

to any such claim which has been or will be settled by the Indemnitee without the prior written consent of the Indemnitor (which consent

will not be unreasonably withheld, delayed or conditioned); provided, however, that notwithstanding the foregoing, the Indemnitee will

not be required to refrain from paying any claim which has matured by a court judgment or decree, unless an appeal is duly taken therefrom

and exercise thereof has been stayed, nor will it be required to refrain from paying any claim where the delay in paying such claim would

result in the foreclosure of a Lien upon any of the property or assets then held by the Indemnitee or where any delay in payment would

cause the Indemnitee material economic loss. The Indemnitor’s right to direct the defense will include the right to compromise or

enter into an agreement settling any claim by a Third Party; provided that no such compromise or settlement will obligate the Indemnitee

to agree to any settlement that requires the taking or restriction of any action (including the payment of money and competition restrictions)

by the Indemnitee (other than the delivery of a release for such claim and customary confidentiality obligations) or that includes any

admission as to fault, culpability or failure to act on the part of the Indemnitee, except with the prior written consent of the Indemnitee

(such consent to be withheld, conditioned or delayed only for a good faith reason). Notwithstanding the Indemnitor’s right to compromise

or settle in accordance with the immediately preceding sentence, the Indemnitor may not settle or compromise any claim over the objection

of the Indemnitee; provided, however, that consent by the Indemnitee to settlement or compromise will not be unreasonably withheld, delayed

or conditioned. The Indemnitee will have the right to participate in the defense of any claim with counsel selected by it subject to the

Indemnitor’s right to direct the defense. The fees and disbursements of such counsel will be at the expense of the Indemnitee; provided,

however, that, in the case of any claim which seeks injunctive or other equitable relief against the Indemnitee, the fees and disbursements

of such counsel will be at the expense of the Indemnitor.

indemnification claim that does not arise from a Third Party claim must be asserted by a written notice to the Purchaser or the Company.

The recipient of such notice will have a period of thirty (30) days after receipt of such notice within which to respond thereto. If the

recipient does not respond within such thirty (30) days, the recipient will be deemed to have accepted responsibility for the Losses set

forth in such notice and will have no further right to contest the validity of such notice. If the recipient responds within such thirty

(30) days after the receipt of the notice and rejects such claim in whole or in part, the party delivering will be free to pursue such

remedies as may be available to it under this Agreement or applicable Law.

8.5. General

Indemnification Provisions.

(a) The

amount of any Losses suffered or incurred by any Indemnitee shall be reduced by the amount of any insurance proceeds or other cash receipts

paid to the Indemnitee or any Affiliate thereof as a reimbursement with respect to such Losses, net of the cost of recovery, the payment

of any deductible, and any increase in premiums (and no right of subrogation shall accrue to any insurer hereunder, except to the extent

that such waiver of subrogation would prejudice any applicable insurance coverage), including any indemnification received by the Indemnitee

or such Affiliate from an unrelated party with respect to such Losses, net of the costs of collection and any related anticipated future

increases in insurance premiums resulting from such Loss or insurance payment.

(b) Notwithstanding

anything in this Agreement to the contrary, for purposes of application of the indemnification provisions of this ARTICLE VIII,

the amount of any Loss arising from the breach of any representation, warranty, covenant, obligation or agreement contained in this Agreement

shall be the entire amount of any Loss actually incurred by the respective Indemnitee as a result of such breach and not just that portion

of the Loss that exceeds the relevant level of materiality, if any.

indemnification obligation of an Indemnitor under this ARTICLE VIII will be paid in cash within three (3) Business Days after the

determination of such obligation in accordance with Section 8.2.

ARTICLE

GENERAL PROVISIONS

9.1. Expenses,

Taxes, Etc. Except as otherwise expressly provided in this Agreement, each party will pay all fees and expenses incurred by it in

connection with the negotiation, execution, delivery of, and the performance under, this Agreement and the consummation of the transactions

contemplated hereby.

9.2. Notices.

Any notice, request, instruction or other document to be given hereunder by a party hereto shall be in writing and shall be deemed to

have been given, (i) when received if given in person or by courier or a courier service, (ii) on the date of transmission if sent by

facsimile or email (with affirmative confirmation of receipt, and provided, that the party providing notice shall within two (2) Business

Days provide notice by another method under this Section 9.2) or (iii) five (5) Business Days after being deposited in the U.S. mail,

certified or registered mail, postage prepaid:

If to the Company, to:

The Elmet Group Co.

280 Fore Street, Suite 301

Portland, Maine 04101

Attn: [*]

Email: [*]

with a copy (which will not constitute notice) to:

Ellenoff Grossman Schole

LLP

1345 Avenue of the Americas, 11th Floor

New York, NY 10105

Attn: [*]

Email: [*]

or to such other individual

or address as a party hereto may designate for itself by notice given as herein provided. The address for such notices and communications

to the Purchaser shall be as set forth on the signature pages attached hereto.

9.3. Interpretation.

The headings and subheadings of this Agreement are for reference and convenience purposes only and in no way modify, interpret or construe

the meaning of specific provisions of the Agreement. In this Agreement, unless the context otherwise requires: (i) whenever required by

the context, any pronoun used in this Agreement shall include the corresponding masculine, feminine or neuter forms, and the singular

form of nouns, pronouns and verbs shall include the plural and vice versa; (ii) reference to any Person includes such Person’s successors

and assigns but, if applicable, only if such successors and assigns are permitted by this Agreement, and reference to a Person in a particular

capacity excludes such Person in any other capacity; (iii) any accounting term used and not otherwise defined in this Agreement has the

meaning assigned to such term in accordance with GAAP; (iv) “including” (and with correlative meaning “include”)

means including without limiting the generality of any description preceding or succeeding such term and shall be deemed in each case

to be followed by the words “without limitation”; (v) the words “herein,” “hereto,” and “hereby”

and other words of similar import in this Agreement shall be deemed in each case to refer to this Agreement as a whole and not to any

particular Section or other subdivision of this Agreement; (vi) the word “if” and other words of similar import when used

herein shall be deemed in each case to be followed by the phrase “and only if”; (vii) the term “or” means “and/or”;

(viii) reference to any Law means such Law as amended, modified, codified or reenacted, in whole or in part, and in effect from time to

time, including rules and regulations promulgated thereunder; (ix) any agreement, instrument, insurance policy, Law or Order defined or

referred to herein or in any agreement or instrument that is referred to herein means such agreement, instrument, insurance policy, Law

or Order as from time to time amended, modified or supplemented, including (in the case of agreements or instruments) by waiver or consent

and (in the case of statutes, regulations, rules or orders) by succession of comparable successor statutes, regulations, rules or orders

and references to all attachments thereto and instruments incorporated therein; and (x) except as otherwise indicated, all references

in this Agreement to the words “Section,” “Schedule” and “Exhibit” are intended to refer to Sections,

Schedules and exhibits to this Agreement. All references to “dollars” or “$” shall refer to, and all payments

hereunder shall be made in, the lawful money of the United States. References to a Person are also to its successors and permitted assigns.

9.4. Severability.

In case any one or more of the provisions contained in this Agreement should be held invalid, illegal or unenforceable in any respect,

the validity, legality, and enforceability of the remaining provisions will not in any way be affected or impaired. Any illegal or unenforceable

term will be deemed to be void and of no force and effect only to the minimum extent necessary to bring such term within the provisions

of applicable Law and such term, as so modified, and the balance of this Agreement will then be fully enforceable. The parties will substitute

for any invalid, illegal or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal

and enforceable, the intent and purpose of such invalid, illegal or unenforceable provision.

9.5. No

Third-Party Beneficiaries. Except for the indemnification rights of the Company Indemnified Parties and Purchaser Indemnified Parties

set forth herein, this Agreement is for the sole benefit of the parties hereto and their successors and permitted assigns and nothing

herein expressed or implied shall give or be construed to give to any Person, other than the parties hereto and such successors and assigns,

any legal or equitable rights hereunder.

9.6. Amendment;

Waiver. This Agreement may not be amended or modified except by an instrument in writing signed by each of the parties hereto. Neither

the failure nor any delay by any party in exercising any right, power or privilege under this Agreement will operate as a waiver of such

right, power or privilege, and single or partial exercise of any such right, power or privilege will preclude any other or further exercise

of such right, power or privilege or the exercise of any other right, power or privilege. To the maximum extent permitted by applicable

Law, (i) no Action or right arising out of this Agreement can be discharged by one party, in whole or in part, by a waiver or renunciation

of the Action or right unless in a writing signed by the party against which such waiver or renunciation is charged; (ii) no waiver that

may be given by a party will be applicable except in the specific instance for which it is given; (iii) no extension of time granted by

any party for the performance of any obligation or act by any other party will be deemed to be an extension of time for the performance

of any other obligation or act hereunder; and (iv) no notice to or demand on one party will be deemed to be a waiver of any obligation

of such party or of the right of the party giving such notice or demand to take further action without notice or demand as provided in

this Agreement or the documents referred to in this Agreement.

9.7. Remedies.

Except as specifically set forth in this Agreement, any party having any rights under any provision of this Agreement will have all rights

and remedies set forth in this Agreement and all rights and remedies which such party may have been granted at any time under any other

contract or agreement and all of the rights which such party may have under any applicable Law. Except as specifically set forth in this

Agreement, any such party will be entitled to (a) enforce such rights specifically, without posting a bond or other security, (b) to recover

damages by reason of a breach of any provision of this Agreement and (c) to exercise all other rights granted by applicable Law. The exercise

of any remedy by a party will not preclude the exercise of any other remedy by such party.

9.8. Mutual

Drafting. The parties acknowledge and agree that: (a) this Agreement is the result of negotiations between the parties and will not

be deemed or construed as having been drafted by any one party; (b) each party and its counsel have reviewed and negotiated the terms

and provisions of this Agreement (including any exhibits attached hereto) and the other Transaction Documents and have contributed to

their revision; (c) the rule of construction to the effect that any ambiguities are resolved against the drafting party will not be employed

in the interpretation of this Agreement; (d) neither the drafting history nor the negotiating history of this Agreement or the other Transaction

Documents may be used or referred to in connection with the construction or interpretation thereof; and (e) the terms and provisions of

this Agreement will be construed fairly as to all parties hereto and not in favor of or against any party, regardless of which party was

generally responsible for the preparation of this Agreement.

9.9. Governing

Law. This Agreement, all acts and transactions pursuant hereto and the rights and obligations of the parties hereunder, and all disputes

and proceedings arising hereunder or in connection herewith, shall be governed by, and construed and enforced in accordance with, the

laws of the State of New York (without giving effect to its choice of law principles to the extent they would result in the application

of the laws of any other jurisdiction).

9.10. Consent

to Jurisdiction; Waivers. For purposes of any Action arising out of or in connection with this Agreement or any transaction contemplated

hereby, each of the parties hereto (a) irrevocably submits to the exclusive jurisdiction and venue of any state or federal court located

within New York County, State of New York, (b) agrees that service of any process, summons, notice or document by U.S. registered mail

to such party’s respective address set forth in Section 9.2 shall be effective service of process for any Action with respect to

any matters to which it has submitted to jurisdiction in this Section 9.10, and (c) waives and covenants not to assert or plead, by way

of motion, as a defense or otherwise, in any such Action, any claim that it is not subject personally to the jurisdiction of such court,

that the Action is brought in an inconvenient forum, that the venue of the Action is improper or that this Agreement or the subject matter

hereof may not be enforced in or by such court, and hereby agrees not to challenge such jurisdiction or venue by reason of any offsets

or counterclaims in any such Action.

9.11. WAIVER

OF TRIAL BY JURY. THE PARTIES HERETO HEREBY KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVE, TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE

LAW, THE RIGHT ANY PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT TO ANY LITIGATION BASED HEREON, OR ARISING OUT OF, UNDER, OR IN CONNECTION

WITH THIS AGREEMENT AND ANY AGREEMENT CONTEMPLATED TO BE EXECUTED IN CONNECTION HEREWITH, OR ANY COURSE OF CONDUCT, COURSE OF DEALING,

STATEMENTS (WHETHER VERBAL OR WRITTEN) OR ACTIONS OF ANY PARTY IN CONNECTION WITH SUCH AGREEMENTS.

9.12. Counterparts.

This Agreement may be executed in one or more counterparts, and by the different parties hereto in separate counterparts, each of which

when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement. A photocopy,

faxed, scanned and/or emailed copy of this Agreement or any other Transaction Documents or any signature page to this Agreement or any

other Transaction Documents, shall have the same validity and enforceability as an originally signed copy.

9.13. Entire

Agreement. This Agreement (including the exhibits and Schedules hereto, which are hereby incorporated herein by reference and deemed

part of this Agreement), together with the other Transaction Documents, constitute the entire agreement among the parties hereto with

respect to the subject matter hereof and supersede all prior agreements and undertakings, both written and oral, with respect to the subject

matter hereof.

[Remainder of Page Intentionally

Left Blank; Signatures Appear on Following Page]

IN WITNESS WHEREOF, the parties

hereto have caused this Agreement to be duly executed and delivered as of the date first written above.

THE ELMET GROUP CO.

By:

/s/ Peter V. Anania

Name:

Peter V. Anania

Title:

Chief Executive Officer and Chairman

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGE FOR PURCHASER FOLLOWS]

[Purchasers signature page follows]

[PURCHASER SIGNATURE PAGES TO ELMT

WARRANT PURCHASE AGREEMENT]

IN WITNESS WHEREOF, the undersigned

have caused this Warrant Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated

above.

Name of Purchaser: Blue Moon Metals Inc.

Signature of Authorized Signatory of Purchaser:

/s/ Christian Kargl-Simard

Name of Authorized Signatory: Christian Kargl-Simard

Title of Authorized Signatory: Chief Executive Officer and Director

Email Address of Authorized Signatory: [*]

Address for Notice to Purchaser:

220 Bay Street, Suite 550, Toronto, Ontario, M5J 2W4 Canada

with copies to (which shall not constitute notice):

Bennett Jones LLP

3400 First Canadian Place

100 King Street West

Toronto, Ontario M5X 1A4

Attention: [*]

Email: [*]

Katten Muchin Rosenman LLP

525 W Monroe St

Chicago, IL 60661

Attention: [*]

Email: [*]

Address for Delivery of Securities to Purchaser (if not same as address

for notice):

Warrant Shares: 1,166,970

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 8

v3.26.3

Cover

Sep. 21, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Sep. 21, 2026

Entity File Number

001-43245

Entity Registrant Name

The Elmet Group Co.

Entity Central Index Key

0002101698

Entity Tax Identification Number

33-1881598

Entity Incorporation, State or Country Code

Entity Address, Address Line One

280 Fore Street

Entity Address, Address Line Two

Suite 301

Entity Address, City or Town

Portland

Entity Address, State or Province

Entity Address, Postal Zip Code

04101

City Area Code

207

Local Phone Number

518-6791

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock, par value $0.001 per share

Trading Symbol

ELMT

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

true

Elected Not To Use the Extended Transition Period

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration